Can Fite Biopharma Ltd.-ADRCANF
13F holders, Q4 2025 (December 31)1holders
$0.00avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Can Fite Biopharma Ltd.-ADR (CANF) in their 13F filings. The largest holder was SBI Securities Co., Ltd. ($0).
- Company
- Can Fite Biopharma Ltd.-ADR
- CUSIP
- 13471N409
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| SBI Securities Co., Ltd. | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is CANF's weight in each manager's 13F, not the share of Can Fite Biopharma Ltd.-ADR the manager owns.